Search
for
Sort by
Research 241–270 of 1000+
- Management of teenagers with polycystic ovarian syndrome
- Pathologies of the skin and its appendages in endocrine diseases
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- Gonads
- Endocrinologia e Medicina Estética Ed. X
- Lifestyle factors affecting the pathogenesis of androgenetic alopecia: a literature review
- Efficacy and Safety of Spironolactone in Acne Management
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- Critical Evaluation of Concept of Genetics in Ayurveda WSR to Eight Undesired Body Types (Ashta Nindit)
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- WNT10B (wingless-type MMTV integration site family)
- Polycystic Ovary Syndrome in Adolescents
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Mucocutaneous reactions to chemotherapy
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Cutaneous complications of chemotherapeutic agents
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Endocrine control of benign prostatic hyperplasia
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- TOXIC EPIDERMAL NECROLYSIS
- Acquired scalp alopecia. Part I: A review
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- Acquired scalp alopecia. Part II: A review
- Parkinson's disease and skin
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels